Development of a novel malignant colorectal polyp prognostic nomogram
ANZ Journal of Surgery · 2025
DOI: 10.1111/ans.19384 ↗At a glance
Journal article in ANZ Journal of Surgery, 2025. Written by Andrew P Zammit and 7 co-authors. Institution: Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia. Major MEDLINE topics: Nomograms, Colorectal Neoplasms, Colonic Polyps. Cited 1 times so far (Crossref); 19 references.
Abstract (original language)
Background
There is uncertainty when determining the optimal treatment for malignant polyps. Clinicians must balance the oncological risk of a malignant polyp with the risk of morbidity and mortality from surgery. This study developed an online risk‐calculator using machine‐learning techniques to predict the risk of an adverse outcome from a malignant colorectal polyp following polypectomy.
Methods
Retrospective data collection of a population‐wide database of all malignant polyps from 2011 to 2020 was performed. Utilizing an artificial intelligence‐based machine learning approach a generalized linear mixed (GLM) model was developed to predict the risk of an adverse outcome after polypectomy. The presence of an adverse outcome was determined by assessing for the presence of residual disease or lymphatic disease if colorectal resection was undertaken. Delayed disease recurrence was also assessed as an additional adverse outcome. Patient and pathological details from the Queensland Cancer Registry were collected and included in the calculator development.
Results
The following variables were included in the final model: age, gender, polyp location (right colon, left colon, rectum), depth of tumour invasion, lymphovascular space invasion, tumour grade, associated polyp type, mismatch repair immunohistochemistry status and margin status. Based on ROC analysis, the AUC for the final GLM model was 0.76. The mean accuracy of the GLM model was 0.76 (95% CI: 0.72–0.80).
Conclusion
This web‐based nomogram will facilitate the discussion of whether individual patients with malignant colorectal polyps can be safely managed with polypectomy or whether the patient should undergo colorectal resection. This nomogram is now available at https://malignantpolyp.com/risk-calculator .
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia.
- Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
- Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research, Royal North Shore Hospital, St Leonards, New South Wales, 2065, Australia.
- NSW Health Pathology, Department of Anatomical Pathology, Royal North Shore Hospital, Sydney, New South Wales, 2065, Australia.
- Sydney Medical School, University of Sydney, Sydney, New South Wales, 2006, Australia.
- Envoi Specialist Pathologists, Brisbane, Queensland, Australia.
ORCID profiles: Andrew P Zammit, Ian Brown, John D Hooper, David A Clark, Talia L Fuchs, Andrew D Riddell, Anthony J Gill
Cite
APA
Zammit, A. P., Aksoy, Y. A., Brown, I., Hooper, J. D., Clark, D. A., Fuchs, T. L., Riddell, A. D., & Gill, A. J. (2025). Development of a novel malignant colorectal polyp prognostic nomogram. ANZ Journal of Surgery. https://doi.org/10.1111/ans.19384
Vancouver
Zammit AP, Aksoy YA, Brown I, Hooper JD, Clark DA, Fuchs TL, et al. Development of a novel malignant colorectal polyp prognostic nomogram. ANZ Journal of Surgery. 2025. doi:10.1111/ans.19384
BibTeX
@article{Zammit2025,
author = {Zammit, Andrew P and Aksoy, Yagiz Alp and Brown, Ian and Hooper, John D and Clark, David A and Fuchs, Talia L and Riddell, Andrew D and Gill, Anthony J},
title = {Development of a novel malignant colorectal polyp prognostic nomogram},
journal = {ANZ Journal of Surgery},
year = {2025},
doi = {10.1111/ans.19384}
}
EUVIMED